These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Infection due to C. difficile ribotype 078: first report of cases in the Republic of Ireland. Burns K; Morris-Downes M; Fawley WN; Smyth E; Wilcox MH; Fitzpatrick F J Hosp Infect; 2010 Aug; 75(4):287-91. PubMed ID: 20621236 [TBL] [Abstract][Full Text] [Related]
4. Diversity of Clostridium difficile PCR ribotypes in Europe: results from the European, multicentre, prospective, biannual, point-prevalence study of Clostridium difficile infection in hospitalised patients with diarrhoea (EUCLID), 2012 and 2013. Davies KA; Ashwin H; Longshaw CM; Burns DA; Davis GL; Wilcox MH; Euro Surveill; 2016 Jul; 21(29):. PubMed ID: 27470194 [TBL] [Abstract][Full Text] [Related]
6. Hospital-based Clostridium difficile infection surveillance reveals high proportions of PCR ribotypes 027 and 176 in different areas of Poland, 2011 to 2013. Pituch H; Obuch-Woszczatyński P; Lachowicz D; Wultańska D; Karpiński P; Młynarczyk G; van Dorp SM; Kuijper EJ; Euro Surveill; 2015; 20(38):. PubMed ID: 26536049 [TBL] [Abstract][Full Text] [Related]
7. Increasing prevalence of the epidemic ribotype 106 in healthcare facility-associated and community-associated Clostridioides difficile infection. Suárez-Bode L; Barrón R; Pérez JL; Mena A Anaerobe; 2019 Feb; 55():124-129. PubMed ID: 30550807 [TBL] [Abstract][Full Text] [Related]
8. Analysis of prevalence, risk factors and molecular epidemiology of Clostridium difficile infection in Kuwait over a 3-year period. Jamal W; Rotimi VO; Brazier J; Duerden BI Anaerobe; 2010 Dec; 16(6):560-5. PubMed ID: 20887795 [TBL] [Abstract][Full Text] [Related]
9. Detection of cross-infection associated to a Brazilian PCR-ribotype of Clostridium difficile in a university hospital in Rio de Janeiro, Brazil. Balassiano IT; dos Santos-Filho J; Vital-Brazil JM; Nouér SA; Souza CR; Brazier JS; Ferreira Ede O; Domingues RM Antonie Van Leeuwenhoek; 2011 Feb; 99(2):249-55. PubMed ID: 20623188 [TBL] [Abstract][Full Text] [Related]
10. Clinical features and characteristics of Clostridium difficile PCR-ribotype 176 infection: results from a 1-year university hospital internal ward study. Drabek J; Nyc O; Krutova M; Stovicek J; Matejkova J; Keil R Ann Clin Microbiol Antimicrob; 2015 Dec; 14():55. PubMed ID: 26698842 [TBL] [Abstract][Full Text] [Related]
11. Incidence, case fatality and genotypes causing Clostridium difficile infections, Finland, 2008. Kotila SM; Virolainen A; Snellman M; Ibrahem S; Jalava J; Lyytikäinen O Clin Microbiol Infect; 2011 Jun; 17(6):888-93. PubMed ID: 20874814 [TBL] [Abstract][Full Text] [Related]
12. A prospective study of community-associated Clostridium difficile infections: the role of antibiotics and co-infections. Taori SK; Wroe A; Hardie A; Gibb AP; Poxton IR J Infect; 2014 Aug; 69(2):134-44. PubMed ID: 24780765 [TBL] [Abstract][Full Text] [Related]
13. Whole-genome sequencing improves discrimination of relapse from reinfection and identifies transmission events among patients with recurrent Clostridium difficile infections. Mac Aogáin M; Moloney G; Kilkenny S; Kelleher M; Kelleghan M; Boyle B; Rogers TR J Hosp Infect; 2015 Jun; 90(2):108-16. PubMed ID: 25935700 [TBL] [Abstract][Full Text] [Related]
14. The emergence of Clostridium difficile ribotypes 027 and 176 with a predominance of the Clostridium difficile ribotype 001 recognized in Slovakia following the European standardized Clostridium difficile infection surveillance of 2016. Novakova E; Stefkovicova M; Kopilec MG; Novak M; Kotlebova N; Kuijper E; Krutova M Int J Infect Dis; 2020 Jan; 90():111-115. PubMed ID: 31707136 [TBL] [Abstract][Full Text] [Related]
15. [Epidemiology of severe Clostridium difficile infections in Hesse, Germany in 2008-2009]. Arvand M; Hauri AM; Zaiss NH; Witte W; Bettge-Weller G Dtsch Med Wochenschr; 2010 Oct; 135(40):1963-7. PubMed ID: 20922636 [TBL] [Abstract][Full Text] [Related]
16. Molecular characteristics of Clostridium difficile strains from patients with a first recurrence more than 8 weeks after the primary infection. Chen Y; Rashid MU; Huang H; Fang H; Nord CE; Wang M; Weintraub A J Microbiol Immunol Infect; 2017 Aug; 50(4):532-536. PubMed ID: 26698688 [TBL] [Abstract][Full Text] [Related]
17. The ClosER study: results from a three-year pan-European longitudinal surveillance of antibiotic resistance among prevalent Clostridium difficile ribotypes, 2011-2014. Freeman J; Vernon J; Pilling S; Morris K; Nicholson S; Shearman S; Longshaw C; Wilcox MH; Clin Microbiol Infect; 2018 Jul; 24(7):724-731. PubMed ID: 29066403 [TBL] [Abstract][Full Text] [Related]
18. Effect of ribotype on all-cause mortality following Clostridium difficile infection. Inns T; Gorton R; Berrington A; Sails A; Lamagni T; Collins J; Perry J; Hill K; Magee J; Gould K J Hosp Infect; 2013 Jul; 84(3):235-41. PubMed ID: 23759667 [TBL] [Abstract][Full Text] [Related]
19. Epidemiological survey of Clostridium difficile ribotypes in the North East of England during an 18-month period. Vanek J; Hill K; Collins J; Berrington A; Perry J; Inns T; Gorton R; Magee J; Sails A; Mullan A; Gould FK J Hosp Infect; 2012 Jul; 81(3):209-12. PubMed ID: 22633277 [TBL] [Abstract][Full Text] [Related]
20. A prospective study of community-associated Clostridium difficile infection in Kuwait: Epidemiology and ribotypes. Jamal W; Pauline E; Rotimi V Anaerobe; 2015 Oct; 35(Pt B):28-32. PubMed ID: 26144314 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]